Urologic oncology

Keyphrases

Publications

volume 42, number 8, 2024

Alex Hannemann, Rodrigo Rodrigues Pessoa, Thomas Flaig, Elizabeth Molina Kuna, Adam Warren, Tyler Robin, Simon P Kim, Eric Ballon-Landa
Cost of upper tract imaging obtained during hematuria evaluation: Analysis of a national claims database. Urologic oncology 42 (8) (2024)
Li Ping Wong, Xiaonan Xu, Haridah Alias, Chuo Yew Ting, Hui Meng Tan, Yulan Lin
Patient- and caregiver-related factors affecting family caregiver burden of urologic cancer patients. Urologic oncology 42 (8) (2024)
Lucas Kastner, Constantin Rieger, David Pfister, Max Schmautz, Enno Storz, Axel Heidenreich
HIVEC as an alternative option in non-muscle-invasive bladder cancer: Experiences from a high-volume center. Urologic oncology 42 (8) (2024)
Brian R Lane, Joseph G Cheaib, Dennis Boynton, Phillip Pierorazio, Sabrina L Noyes, Henry Peabody, Nirmish Singla, Anna Johnson, Khurshid R Ghani, Andrew Krumm, Karandeep Singh
Development and validation of a multicenter Cox regression model to predict all-cause mortality in patients with renal masses suspicious for renal cancer. Urologic oncology 42 (8) (2024)
Berdine L Heesterman, Katja K H Aben, Alfons C M van den Bergh, Jochem R N van der Voort van Zyp, Leonard P Bokhorst
Overall survival benefit of androgen suppression in addition to dose-escalated external beam radiotherapy for high-risk prostate cancer: Nationwide real-world data indicates a shift in men that benefit. Urologic oncology 42 (8) (2024)
Carmen Gómez Del Cañizo, Ignacio González Ginel, Cristina Martín-Arriscado Arroba, Ana de la Calle Moreno, Mario Hernández Arroyo, Alfredo Rodríguez Antolín, Félix Guerrero Ramos
Voided urine cytology is a useful tool predicting non-muscle-invasive bladder cancer risk before surgery. Urologic oncology 42 (8) (2024)
Akira Kazama, Carlos Munoz-Lopez, Worapat Attawettayanon, Melissa Boumitri, Eran Maina, Zaeem Lone, Nityam Rathi, Kieran Lewis, Rebecca A Campbell, Diego Aguilar Palacios, Jihad Kaouk, Georges-Pascal Haber, Samuel Haywood, Nima Almassi, Christopher J Weight, Erick M Remer, Ryan Ward, Amy S Nowacki, Steven C Campbell
Parenchymal obliteration by renal masses: Functional and oncologic implications. Urologic oncology 42 (8) (2024)
Anis Assad, Francesco Barletta, Reha-Baris Incesu, Lukas Scheipner, Simone Morra, Andrea Baudo, Cristina Cano Garcia, Zhe Tian, Sascha Ahyai, Nicola Longo, Felix K H Chun, Shahrokh F Shariat, Derya Tilki, Alberto Briganti, Fred Saad, Pierre I Karakiewicz
Prognostic significance of lymph node count in surgically treated patients with T 2-4 stage nonmetastatic adrenocortical carcinoma. Urologic oncology 42 (8) (2024)
Francesco Cei, Alessandro Larcher, Giuseppe Rosiello, Giuseppe Basile, Giacomo Musso, Chiara Re, Giuseppe Fallara, Federico Belladelli, Giorgio Brembilla, Giorgia Guazzarotti, Francesco De Cobelli, Laura Marandino, Andrea Necchi, Alberto Briganti, Andrea Salonia, Roberto Bertini, Francesco Montorsi, Umberto Capitanio
Preoperative risk calculator for the probability of completing nephron sparing for kidney cancer. Urologic oncology 42 (8) (2024)
Bruce Gao, Antonio R H Gorgen, Rohit Bhatt, Zachary E Tano, Kalon L Morgan, Kelvin Vo, Sina Soltanzadeh Zarandi, Sohrab N Ali, Pengbo Jiang, Roshan M Patel, Ralph V Clayman, Jaime Landman
Avoiding "Needless" nephrectomy: What is the role of small renal mass biopsy in 2024? Urologic oncology 42 (8) (2024)
Zhi-Yu Zhang, Jian-Hao Xu, Jiang-Lei Zhang, Yu-Xin Lin, Jun Ou-Yang
Pro-cancer role of CD276 as a novel biomarker for clear cell renal cell carcinoma. Urologic oncology 42 (8) (2024)
Zhi-Yu Zhang, Jian-Hao Xu, Jiang-Lei Zhang, Yu-Xin Lin, Jun Ou-Yang
Pro-cancer role of CD276 as a novel biomarker for clear cell renal cell carcinoma. Urologic oncology 42 (8) (2024)
Jianrui Ji, Yunsong Liu, Yongxing Bao, Yu Men, Zhouguang Hui
Network analysis of histopathological image features and genomics data improving prognosis performance in clear cell renal cell carcinoma. Urologic oncology 42 (8) (2024)
Haim Herzberg, Yossi Ventura, Karin Lifshitz, Ziv Savin, Shay Golan, Jack Baniel, Ofer Yossepowitch, Roy Mano
Natural history and health care burden of non-curative treatment for muscle-invasive bladder cancer. Urologic oncology 42 (8) (2024)
Brian R Lane, Joseph G Cheaib, Dennis Boynton, Phillip Pierorazio, Sabrina L Noyes, Henry Peabody, Nirmish Singla, Anna Johnson, Khurshid R Ghani, Andrew Krumm, Karandeep Singh
Development and validation of a multicenter Cox regression model to predict all-cause mortality in patients with renal masses suspicious for renal cancer. Urologic oncology 42 (8) (2024)
Haim Herzberg, Yossi Ventura, Karin Lifshitz, Ziv Savin, Shay Golan, Jack Baniel, Ofer Yossepowitch, Roy Mano
Natural history and health care burden of non-curative treatment for muscle-invasive bladder cancer. Urologic oncology 42 (8) (2024)
Bruce Gao, Antonio R H Gorgen, Rohit Bhatt, Zachary E Tano, Kalon L Morgan, Kelvin Vo, Sina Soltanzadeh Zarandi, Sohrab N Ali, Pengbo Jiang, Roshan M Patel, Ralph V Clayman, Jaime Landman
Avoiding "Needless" nephrectomy: What is the role of small renal mass biopsy in 2024? Urologic oncology 42 (8) (2024)
Yair Lotan, Piyush Agarwal, Peter Black, Rian Dickstein, Ashish M Kamat, Byron Lee, Vikram M Narayan, Sima Porten, Sarah P Psutka, Armine K Smith, Robert S Svatek, Stephen B Williams, Solomon Woldu
Standardization of the evaluation and surveillance of patients with BCG unresponsive high grade non-muscle invasive bladder cancer clinical trials. Urologic oncology 42 (8) (2024)
Natalya Benderska-Söder, Thorsten Ecke, Lisa Kleinlein, Florian Roghmann, Ekkehardt Bismarck, Bas W G van Rhijn, Arnulf Stenzl, Johannes Alfred Witjes, Tilman Todenhöfer, Oliver W Hakenberg, Marc Oliver Grimm, Peter J Goebell, Maximilian Burger, Jorgen Bjerggaard Jensen, Bernd J Schmitz-Dräger
Simulation of the effects of molecular urine markers in follow-up of patients with high-risk non-muscle invasive bladder cancer. Urologic oncology 42 (8) (2024)

volume 42, number 9, 2024

Hiroki Ishihara, Koichi Nishimura, Takashi Ikeda, Hironori Fukuda, Kazuhiko Yoshida, Junpei Iizuka, Tsunenori Kondo, Toshio Takagi
Impact of body composition on outcomes of immune checkpoint inhibitor combination therapy in patients with previously untreated advanced renal cell carcinoma. Urologic oncology 42 (9) (2024)
Michael E Rezaee, Roy Elias, Howard L Li, Pranjal Agrawal, Maximilian Pallauf, Dmitry Enikeev, Yasser Ged, Scott Eggener, Nirmish Singla
Survival outcomes and molecular drivers of testicular cancer in hispanic men. Urologic oncology 42 (9) (2024)
Jessica Y Hsueh, Daniel Nethala, Shiva Singh, W Marston Linehan, Mark W Ball
Investigating the clinical reasoning abilities of large language model GPT-4: an analysis of postoperative complications from renal surgeries. Urologic oncology 42 (9) (2024)
Nadine A Friedrich, Michael Luu, Rebecca Gale, Antwon Chaplin, Leslie Ballas, Howard M Sandler, Edwin M Posadas, Stephen J Freedland, Brennan Spiegel, Paul Kokorowski, Timothy J Daskivich
Variation in content discussed by specialty in consultations for clinically localized prostate cancer. Urologic oncology 42 (9) (2024)
Mohamad Abou Chakra, Ian M McElree, Vignesh T Packiam, Sarah L Mott, Michael A O'Donnell
Early experience with sequential intravesical gemcitabine and docetaxel for micropapillary variant non-muscle invasive bladder cancer. Urologic oncology 42 (9) (2024)
Yulong Wang, Yuxuan Song, Yun Peng, Songchen Han, Caipeng Qin, Yiqing Du, Tao Xu
Effects of androgen suppression therapy on the incidence and prognosis of bladder cancer: An updated systematic review and meta-analysis. Urologic oncology 42 (9) (2024)
Justin W Ingram, Rainjade Chung, Caroline Laplaca, James M McKiernan, Andrew T Lenis, Christopher B Anderson
Incidence and management of prostatic urethra recurrence in a cohort of 21 patients who received BCG induction for non-muscle invasive bladder cancer. Urologic oncology 42 (9) (2024)
Sanjana Ranganathan, Carlos Riveros, Jiaqiong Xu, Siqi Hu, Michael Geng, Emily Huang, Zachary Melchiode, Jun Zhang, Eleni Efstathiou, Keith Syson Chan, Christopher J D Wallis, Guru Sonpavde, Raj Satkunasivam
Chemotherapy, immunotherapy, or combination first-line treatment for metastatic urothelial carcinoma of the bladder: A large real-world experience. Urologic oncology 42 (9) (2024)
Francesco Ditonno, Antonio Franco, Alessandro Veccia, Riccardo Bertolo, Zhenjie Wu, Linhui Wang, Firas Abdollah, Marco Finati, Giuseppe Simone, Gabriele Tuderti, Emma Helstrom, Andres Correa, Ottavio De Cobelli, Matteo Ferro, Francesco Porpiglia, Daniele Amparore, Antonio Tufano, Sisto Perdonà, Raj Bhanvadia, Vitaly Margulis, Stephan Brönimann, Nirmish Singla, Dhruv Puri, Ithaar H Derweesh, Dinno F Mendiola, Mark L Gonzalgo, Reuben Ben-David, Reza Mehrazin, Sol C Moon, Soroush Rais-Bahrami, Courtney Yong, Chandru P Sundaram, Farshad Sheybaee Moghaddam, Alireza Ghoreifi, Hooman Djaladat, Riccardo Autorino, Alessandro Antonelli
Decisional and prognostic impact of diagnostic ureteroscopy in high-risk upper tract urothelial carcinoma: A multi-institutional collaborative analysis (ROBUUST collaborative group). Urologic oncology 42 (9) (2024)
Jacob Knorr, Zaeem Lone, Glenn Werneburg, Ava Adler, Jose Agudelo, Mangesh Suryavanshi, Rebecca A Campbell, Kyle Ericson, Hong Qiu, Petar Bajic, Georges-Pascal Haber, Christopher J Weight, Philip P Ahern, Nima Almassi, Aaron W Miller, Byron H Lee
An exploratory study investigating the impact of the bladder tumor microbiome on Bacillus Calmette Guerin (BCG) response in non-muscle invasive bladder cancer. Urologic oncology 42 (9) (2024)
Tarek Ajami, Ruben Blachman-Braun, Joao G Porto, Chad R Ritch, Mark L Gonzalgo, Sanoj Punnen, Hemendra N Shah, Dipen J Parekh, Bruno Nahar
Combined holmium laser enucleation of the prostate with high-intensity focused ultrasound in treating patients with localized prostate cancer in a prostate with volume > 60 g: Oncological and functional outcomes from single-institution study. Urologic oncology 42 (9) (2024)
Nadine A Friedrich, Michael Luu, Rebecca Gale, Antwon Chaplin, Leslie Ballas, Howard M Sandler, Edwin M Posadas, Stephen J Freedland, Brennan Spiegel, Paul Kokorowski, Timothy J Daskivich
Variation in content discussed by specialty in consultations for clinically localized prostate cancer. Urologic oncology 42 (9) (2024)
Bahadır Şahin, Serhat Çetin, Sinan Sözen, Güven Aslan, Serdar Çelik, Levent Türkeri
A novel nomogram to predict clinically significant prostate cancer in MR assisted lesion biopsies: Turkish urooncology association nomogram. Urologic oncology 42 (9) (2024)
Jacob Knorr, Zaeem Lone, Glenn Werneburg, Ava Adler, Jose Agudelo, Mangesh Suryavanshi, Rebecca A Campbell, Kyle Ericson, Hong Qiu, Petar Bajic, Georges-Pascal Haber, Christopher J Weight, Philip P Ahern, Nima Almassi, Aaron W Miller, Byron H Lee
An exploratory study investigating the impact of the bladder tumor microbiome on Bacillus Calmette Guerin (BCG) response in non-muscle invasive bladder cancer. Urologic oncology 42 (9) (2024)
Yiran Mao, Tingting Xia, Hailing Wang, Xi Wei, Jie Mu
Evaluation of image-pro plus assisted superb microvascular imaging for differential diagnosis of renal masses. Urologic oncology 42 (9) (2024)
M Teresa Melgarejo Segura, Yaiza Yáñez Castillo, Macarena Lozano Lorca, Ana Morales Martínez, Miguel Ángel Arrabal Polo, Miguel Arrabal Martín
Efficacy of conduction hyperthermia in the treatment of non-muscle invasive bladder cancer: A systematic review. Urologic oncology 42 (9) (2024)
Shuying Zhu, Jing He, Liliang Yin, Jiawei Zhou, Jiayi Lian, Yanli Ren, Xinling Zhang, Jinghua Yuan, Gang Wang, Xiaoping Li
Matrix metalloproteinases targeting in prostate cancer. Urologic oncology 42 (9) (2024)
Pedro de Pablos-Rodríguez, Francesco Claps, Ana Aldaz Acín, Álvaro Gómez-Ferrer, Augusto Wong, Juan Boronat Catalá, Ana Calatrava Fons, Antonio Coy García, Juan Casanova-Ramón Borja, Miguel Ramírez Backhaus
Prostate cancer patients with lymphatic node involvement detected by immunohistochemistry. Is the effort worthwhile? Urologic oncology 42 (9) (2024)
Michael Massari, Padraic O'Malley, Tarik Benidir, Li-Ming Su, Hanzhi Gao, Paul L Crispen
Efficacy of BCG for non-muscle invasive bladder cancer following nephroureterectomy for upper tract urothelial carcinoma. Urologic oncology 42 (9) (2024)
J Bradley Mason, Arnav Srivastava, Nicholas J Lanzotti, Jeffrey L Ellis, Heather N Di Carlo, John P Gearhart, Diana K Bowen, Mohit Gupta, Maria M Picken, Gopal N Gupta, Hiten D Patel
Variations in germ cell tumor histology by age and implications for cancer-specific survival among pediatric and adult males: A population-based study. Urologic oncology 42 (9) (2024)
Mohamad Abou Chakra, Ian M McElree, Vignesh T Packiam, Sarah L Mott, Michael A O'Donnell
Early experience with sequential intravesical gemcitabine and docetaxel for micropapillary variant non-muscle invasive bladder cancer. Urologic oncology 42 (9) (2024)
Nadine A Friedrich, Michael Luu, Rebecca Gale, Antwon Chaplin, Leslie Ballas, Howard M Sandler, Edwin M Posadas, Stephen J Freedland, Brennan Spiegel, Paul Kokorowski, Timothy J Daskivich
Variation in content discussed by specialty in consultations for clinically localized prostate cancer. Urologic oncology 42 (9) (2024)
M Teresa Melgarejo Segura, Yaiza Yáñez Castillo, Macarena Lozano Lorca, Ana Morales Martínez, Miguel Ángel Arrabal Polo, Miguel Arrabal Martín
Efficacy of conduction hyperthermia in the treatment of non-muscle invasive bladder cancer: A systematic review. Urologic oncology 42 (9) (2024)
Jessica Y Hsueh, Daniel Nethala, Shiva Singh, W Marston Linehan, Mark W Ball
Investigating the clinical reasoning abilities of large language model GPT-4: an analysis of postoperative complications from renal surgeries. Urologic oncology 42 (9) (2024)
Nadine A Friedrich, Michael Luu, Rebecca Gale, Antwon Chaplin, Leslie Ballas, Howard M Sandler, Edwin M Posadas, Stephen J Freedland, Brennan Spiegel, Paul Kokorowski, Timothy J Daskivich
Variation in content discussed by specialty in consultations for clinically localized prostate cancer. Urologic oncology 42 (9) (2024)
Mohamad Abou Chakra, Ian M McElree, Vignesh T Packiam, Sarah L Mott, Michael A O'Donnell
Early experience with sequential intravesical gemcitabine and docetaxel for micropapillary variant non-muscle invasive bladder cancer. Urologic oncology 42 (9) (2024)
J Bradley Mason, Arnav Srivastava, Nicholas J Lanzotti, Jeffrey L Ellis, Heather N Di Carlo, John P Gearhart, Diana K Bowen, Mohit Gupta, Maria M Picken, Gopal N Gupta, Hiten D Patel
Variations in germ cell tumor histology by age and implications for cancer-specific survival among pediatric and adult males: A population-based study. Urologic oncology 42 (9) (2024)
Francesco Ditonno, Antonio Franco, Alessandro Veccia, Riccardo Bertolo, Zhenjie Wu, Linhui Wang, Firas Abdollah, Marco Finati, Giuseppe Simone, Gabriele Tuderti, Emma Helstrom, Andres Correa, Ottavio De Cobelli, Matteo Ferro, Francesco Porpiglia, Daniele Amparore, Antonio Tufano, Sisto Perdonà, Raj Bhanvadia, Vitaly Margulis, Stephan Brönimann, Nirmish Singla, Dhruv Puri, Ithaar H Derweesh, Dinno F Mendiola, Mark L Gonzalgo, Reuben Ben-David, Reza Mehrazin, Sol C Moon, Soroush Rais-Bahrami, Courtney Yong, Chandru P Sundaram, Farshad Sheybaee Moghaddam, Alireza Ghoreifi, Hooman Djaladat, Riccardo Autorino, Alessandro Antonelli
Decisional and prognostic impact of diagnostic ureteroscopy in high-risk upper tract urothelial carcinoma: A multi-institutional collaborative analysis (ROBUUST collaborative group). Urologic oncology 42 (9) (2024)
Michael Massari, Padraic O'Malley, Tarik Benidir, Li-Ming Su, Hanzhi Gao, Paul L Crispen
Efficacy of BCG for non-muscle invasive bladder cancer following nephroureterectomy for upper tract urothelial carcinoma. Urologic oncology 42 (9) (2024)
Michael E Rezaee, Roy Elias, Howard L Li, Pranjal Agrawal, Maximilian Pallauf, Dmitry Enikeev, Yasser Ged, Scott Eggener, Nirmish Singla
Survival outcomes and molecular drivers of testicular cancer in hispanic men. Urologic oncology 42 (9) (2024)
Jessica Y Hsueh, Daniel Nethala, Shiva Singh, W Marston Linehan, Mark W Ball
Investigating the clinical reasoning abilities of large language model GPT-4: an analysis of postoperative complications from renal surgeries. Urologic oncology 42 (9) (2024)